137 related articles for article (PubMed ID: 17127294)
1. Osteopontin: a novel inflammatory mediator of cardiovascular disease.
Singh M; Ananthula S; Milhorn DM; Krishnaswamy G; Singh K
Front Biosci; 2007 Jan; 12():214-21. PubMed ID: 17127294
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin in cardiovascular disease: a potential therapeutic target.
Waller AH; Sanchez-Ross M; Kaluski E; Klapholz M
Cardiol Rev; 2010; 18(3):125-31. PubMed ID: 20395697
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin in Vascular Disease.
Lok ZSY; Lyle AN
Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):613-622. PubMed ID: 30727754
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease.
Scatena M; Liaw L; Giachelli CM
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2302-9. PubMed ID: 17717292
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin mediates macrophage chemotaxis via α4 and α9 integrins and survival via the α4 integrin.
Lund SA; Wilson CL; Raines EW; Tang J; Giachelli CM; Scatena M
J Cell Biochem; 2013 May; 114(5):1194-202. PubMed ID: 23192608
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation.
O'Regan A; Berman JS
Int J Exp Pathol; 2000 Dec; 81(6):373-90. PubMed ID: 11298186
[TBL] [Abstract][Full Text] [Related]
7. Peptide-based vaccination against OPN integrin binding sites does not improve cardio-metabolic disease in mice.
Grün NG; Strohmeier K; Moreno-Viedma V; Le Bras M; Landlinger C; Zeyda K; Wanko B; Leitner L; Staffler G; Zeyda M; Stulnig TM
Immunol Lett; 2016 Nov; 179():85-94. PubMed ID: 27639826
[TBL] [Abstract][Full Text] [Related]
8. Expression, roles, receptors, and regulation of osteopontin in the kidney.
Xie Y; Sakatsume M; Nishi S; Narita I; Arakawa M; Gejyo F
Kidney Int; 2001 Nov; 60(5):1645-57. PubMed ID: 11703581
[TBL] [Abstract][Full Text] [Related]
9. The multiple functions and mechanisms of osteopontin.
Icer MA; Gezmen-Karadag M
Clin Biochem; 2018 Sep; 59():17-24. PubMed ID: 30003880
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells.
Lee JL; Wang MJ; Sudhir PR; Chen GD; Chi CW; Chen JY
Cancer Res; 2007 Mar; 67(5):2089-97. PubMed ID: 17332338
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer.
Ramaiah SK; Rittling S
Toxicol Sci; 2008 May; 103(1):4-13. PubMed ID: 17890765
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin - a multi-modal marker and mediator in atherosclerotic vascular disease.
Wolak T
Atherosclerosis; 2014 Oct; 236(2):327-37. PubMed ID: 25128758
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin as a new player in mast cell biology.
Bulfone-Paus S; Paus R
Eur J Immunol; 2008 Feb; 38(2):338-41. PubMed ID: 18228246
[TBL] [Abstract][Full Text] [Related]
14. Role of osteopontin in regulating hepatic inflammatory responses and toxic liver injury.
Ramaiah SK; Rittling S
Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):519-26. PubMed ID: 17696803
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin alters endothelial and valvular interstitial cell behaviour in calcific aortic valve stenosis through HMGB1 regulation.
Passmore M; Nataatmadja M; Fung YL; Pearse B; Gabriel S; Tesar P; Fraser JF
Eur J Cardiothorac Surg; 2015 Sep; 48(3):e20-9. PubMed ID: 26273067
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases.
Uede T
Pathol Int; 2011 May; 61(5):265-80. PubMed ID: 21501293
[TBL] [Abstract][Full Text] [Related]
17. [The role of osteopontin in cardiovascular diseases].
Witkiewicz W; Czyzewska-Buczyńska A; Bałasz S; Gnus JJ
Pol Merkur Lekarski; 2010 Aug; 29(170):79-83. PubMed ID: 20842817
[TBL] [Abstract][Full Text] [Related]
18. Coordinate expression of OPN and associated receptors during monocyte/macrophage differentiation of HL-60 cells.
Atkins K; Berry JE; Zhang WZ; Harris JF; Chambers AF; Simpson RU; Somerman MJ
J Cell Physiol; 1998 May; 175(2):229-37. PubMed ID: 9525482
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin.
Zhu B; Suzuki K; Goldberg HA; Rittling SR; Denhardt DT; McCulloch CA; Sodek J
J Cell Physiol; 2004 Jan; 198(1):155-67. PubMed ID: 14584055
[TBL] [Abstract][Full Text] [Related]
20. Immobilized Osteopontin Enhances Adhesion but Suppresses Cytokine Release of Anti-IgE Activated Human Mast Cells.
Ng CW; Tam IYS; Sam SW; Yu Y; Lau HYA
Front Immunol; 2018; 9():1109. PubMed ID: 29872439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
